| Announce Date | 10/06/2025 |
| EPS Normalized Actual | $0.01 In Line |
| EPS GAAP Actual | $0.01 In Line |
| Revenue Actual | $0.010969B |
| Revenue Surprise | Beat by $10.969M |
| Announce Date | 11/28/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.0375 |
| EPS GAAP Estimate | $0.0375 |
| Revenue Estimate | $0.0182B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| May 2030 | 1.14 | 21.47 | 1.05712 | 1.20718 | 1 |
| May 2030 | 1.14 | 21.47 | 1.12019 | 1.15626 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | -0.07 | -0.073333 | 0.010969B | -19.6% | -0.51M |
| FQ2 2025 (May 2025) | -0.0972 | -0.0972 | 0.014089B | -17.82% | 14.09M |
| FQ1 2025 (Feb 2025) | -0.02 | -0.02 | 0.018307B | 58.69% | 18.31M |
| FQ4 2024 (Nov 2024) | -0.0347 | -0.0347 | 0.013453B | -59.3% | 13.45M |
| FQ3 2024 (Aug 2024) | 0.0227 | 0.0227 | 0.013119B | -57.21% | 13.12M |
| FQ2 2024 (May 2024) | 0.82 | 0.82 | 0.0166B | -34.15% | 16.6M |
| FQ1 2024 (Feb 2024) | -0.051 | -0.051 | 0.007563B | -127.5% | 7.56M |
| FQ4 2023 (Nov 2023) | 0.21 | 0.21 | 0.021431B | 30.87% | 21.43M |
FQ4 Announce Date
11/28/2025 (Pre-Market)
Consensus EPS Estimates
0.0375
Consensus Revenue Estimates
0.0182B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (May 2027) | 0.0218 | -- | 0.02022186 | 0.02337814 | 1 |
| FQ1 2027 (Feb 2027) | 0.0376 | -- | 0.0376 | 0.0376 | 1 |
| FQ4 2026 (Nov 2026) | 0.0177 | -- | 0.01641867 | 0.01898133 | 1 |
| FQ3 2026 (Aug 2026) | 0.0177 | 495.48 | 0.01641867 | 0.01898133 | 1 |
| FQ2 2026 (May 2026) | 0.102 | 195.29 | 0.1015 | 0.1025 | 1 |
| FQ1 2026 (Feb 2026) | 0.0371 | 153.91 | 0.03651284 | 0.03768716 | 1 |
| FQ4 2025 (Nov 2025) | 0.0375 | 192.53 | 0.03690651 | 0.03809349 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (May 2027) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ1 2027 (Feb 2027) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ4 2026 (Nov 2026) | 0.02B | -- | 0.01B | 0.02B | 1 |
| FQ3 2026 (Aug 2026) | 0.02B | 28.63 | 0.01B | 0.02B | 1 |
| FQ2 2026 (May 2026) | 0.02B | 43.19 | 0.02B | 0.02B | 1 |
| FQ1 2026 (Feb 2026) | 0.02B | -0.04 | 0.02B | 0.02B | 1 |
| FQ4 2025 (Nov 2025) | 0.02B | 26.08 | 0.02B | 0.02B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | 0.003333 | -0.07 | -0.073333 | 104.76% |
| FQ2 2025 (May 2025) | -0.0972 | -0.0972 | 100% | |
| FQ1 2025 (Feb 2025) | -0.02 | -0.02 | 100% | |
| FQ4 2024 (Nov 2024) | -0.0347 | -0.0347 | 100% | |
| FQ3 2024 (Aug 2024) | 0.0227 | 0.0227 | 100% | |
| FQ2 2024 (May 2024) | 0.82 | 0.82 | 100% | |
| FQ1 2024 (Feb 2024) | -0.051 | -0.051 | 100% | |
| FQ4 2023 (Nov 2023) | 0.21 | 0.21 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | $0.01B | $0.01B | $-0.51M | -4.64% |
| FQ2 2025 (May 2025) | $0B | $0.01B | $14.09M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $0.02B | $18.31M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $0.01B | $13.45M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $0.01B | $13.12M | 100% |
| FQ2 2024 (May 2024) | $0B | $0.02B | $16.6M | 100% |
| FQ1 2024 (Feb 2024) | $0B | $0.01B | $7.56M | 100% |
| FQ4 2023 (Nov 2023) | $0B | $0.02B | $21.43M | 100% |